/
SNN
$29.81-$0.30 (-1.00%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$12.5B
419M shares
52-week range
$28.56 – $38.79
12% from low
Exchange
NYSE
ADRC
Change$-8.47
Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
www.smith-nephew.com- Employees
- 17,000
- IPO / List date
- Nov 16, 1999
Held by traders on TradeandTell
No one on the platform currently holds SNN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 275,461 | $8.8M |
| Renaissance Technologiesas of 2025-06-30 | 96,250 | $2.9M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 5.22% ($1.56/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-10-02 | $0.3120 | 2026-11-06 |
| 2026-03-27 | $0.4820 | 2026-05-27 |
| 2025-10-03 | $0.3000 | 2025-11-07 |
| 2025-03-28 | $0.4620 | 2025-05-28 |
| 2024-10-04 | $0.2880 | 2024-11-08 |
| 2024-04-01 | $0.4620 | 2024-05-22 |
| 2023-10-05 | $0.2880 | 2023-11-01 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2014-10-15 | 2.5-for-1 |
| 2003-12-16 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded SNN yet.
